The interventional science theme is focused on the development of clinical devices, technologies, methodologies and tools that can improve cancer diagnosis, treatment and therapy monitoring. Most importantly, our goal is to increase the success rate of clinical adoption for our innovative technologies to make a real-world difference for the patients.

    Doctor treating patient in ward

    Bringing convergence to the bedside

    The application of convergence science to medical interventions focuses technological development around the needs of the practitioners and patients. The challenges surrounding clinical adoption often arise from inadequate clinical positioning or the lack of knowledge of real-world clinical needs. The theme of Interventional Science aims to fully position our innovations within the real-world ecosystem. We want our technologies to be tested, developed and optimised with the know-how and acceptance of the people who ultimately use them. This means to confront our ideas to patients, clinicians and practitioners for them to open our eyes on the reality of their experience with medical technologies. The innovations we aim to promote will span across the entire patient journey from early detection and diagnostics, therapy monitoring devices, biologically informed surgical innovations, novel interventions and real-time image guidance for radiotherapy. We wish to innovate in devices that can be used during therapy to assess the precision of the intervention and/or the immediate response to the treatment as well as devices monitoring the medium to long term response to therapy, particularly technologies usable at home, preventing therapy failure, rehospitalisation and relapses or improving the patient wellbeing and quality of life. We support methodologies aimed at improving clinical decisions, addressing patient stratification, diagnosis refinement, and triage of patients




    If you have any questions relating to the Interventional Science theme please contact Dr Chloe Stockford  (